Interesting paper - enzalutamide/ADT in MHSPCa has some excellent results.

[Don_1213]

Another interesting paper: onclive.com/view/enzalutami...

Adding enzalutamide to ADT in metastatic-hormone-sensitive PCa has some surprisingly good results...

Quote from it: "Results showed that the addition of enzalutamide to ADT reduced the risk of radiographic progression or death by 61% (95% CI, 0.30-0.50) vs ADT alone in the overall patient population."

[Schwah]

Yes. Every single phase 3 study has shown huge advantages to adding key drugs (Zytega/chemoXandi etc etc) earlier. Yet so many men here still advocate sequential use of these drugs so as to give them more time.

Schwah

[Islandboy2021]

My Oncologist would like to add Apalutamide to my treatment. At the moment I am only having 3 months Zoladex injections. I am not yet castrate resistant. PSA has risen to 0.18 from 0.02. Waiting to get scans done to see if bone mets have come back.